Back

Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials I Heart Failure HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Samira Lakhal-Littleton

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors: Insights from Four Large-scale Placebo-Controlled Outcome Trials
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CANVAS Program, CREDENCE, DAPA-HF, and DELIVER
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
Discussant review - IV iron and the heart
Professor E. Jankowska (Wroclaw, PL)
Slides Video
Presentation thumbnail
Impact of a remote monitoring program on all-cause mortality of patients with heart failure: National, real-world evidence of the TELESAT study
Professor N. Girerd (Nancy, FR)
Slides Video
Presentation thumbnail
Discussant review - TELESAT
Doctor M. Costanzo (Naperville, US)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials I
Video

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Iron metabolism in heart failure
thumbnail
Congress Presentation
Discussant review - IV iron and the heart
thumbnail
Congress Presentation
Iron therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources